Ovarian cancer is one of the most common and deadly cancers in women, yet it often goes undetected until it has progressed to an advanced stage. This is because the symptoms of ovarian cancer are often subtle and easily mistaken for other, less serious conditions. It is important for women and their doctors to be aware of the signs and symptoms of ovarian cancer, so that it can be detected and treated as early as possible. This article will discuss the hidden symptoms of ovarian cancer, and how to recognize them.
Ovarian cancer is a type of cancer that starts in the ovaries, the reproductive organs in women that produce eggs. It is the fifth most common cancer in women, and the leading cause of death among gynecologic cancers. The American Cancer Society estimates that in 2021, about 24,000 women in the United States will be diagnosed with ovarian cancer, and about 14,000 will die from the disease.
The exact cause of ovarian cancer is unknown, but there are several risk factors that are associated with an increased risk of developing the disease. These include increasing age, a family history of ovarian cancer, genetic mutations, obesity, and certain lifestyle factors such as smoking.
The symptoms of ovarian cancer can be difficult to detect, as they can be subtle and easily mistaken for other less serious conditions. The most common symptom is abdominal or pelvic pain, but other symptoms may include bloating, feeling full quickly, changes in bowel habits, and urinary symptoms such as an urgent need to urinate. Other symptoms may include fatigue, indigestion, back pain, and unexplained weight loss.
If a woman is experiencing any of the symptoms of ovarian cancer, her doctor will usually perform a physical exam, followed by imaging tests such as an ultrasound or CT scan. A biopsy may also be performed to confirm the diagnosis. Once a diagnosis is confirmed, the doctor will stage the cancer, which is a way of determining how far it has progressed.
Treatment for ovarian cancer depends on the stage of the cancer and other factors. The most common treatments are surgery, chemotherapy, and radiation therapy. In some cases, a combination of these treatments may be recommended. In addition, there are newer treatments such as targeted therapy and immunotherapy that may be used to treat ovarian cancer.
Ovarian cancer is a serious and potentially deadly disease, but early detection and treatment can lead to better outcomes. It is important for women and their doctors to be aware of the hidden symptoms of ovarian cancer, so that it can be detected and treated as early as possible. If you are experiencing any of the symptoms of ovarian cancer, it is important to contact your doctor to discuss your concerns and get the necessary tests to determine if you have the disease.
1.
Report provides global picture of wide inequalities in care for women's cancers
2.
A hint regarding aspirin, the connection to colon cancer, the approval of the new Lutathera, artificial intelligence, and electronic records.
3.
Kate Middleton and Remission: Oncologists Weigh In
4.
In a randomized trial, the kinder, gentler regimen for classical Hodgkin wins out.
5.
Mental health risk persists years after cancer diagnosis
1.
The Basics of Langerhans Cell Histiocytosis: Understanding a Rare Disease
2.
Esophageal Cancer Survival Rates and Outcomes: Evidence-Based Insights from Oncology Studies
3.
A Revolutionary Guide to Calculating Absolute Neutrophil Counts
4.
Studying Lactic Acid in Pediatric Tumor Microenvironments: Experimental Approaches Explored
5.
Harnessing Artificial Intelligence in Oncology: Innovations in Diagnosis, Treatment, and Patient Care
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V
2.
From Relapse to Remission Mapping the Treatment Journey in Adult R R B Cell ALL The Critical Goal of MRD
3.
The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion
4.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
5.
Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation